logo-loader
CSE:XPHY

XPhyto Therapeutics Corp.

Receive alerts
Market:
CSE
Market Cap:
$159.13 m
Price
3.27 CAD
Change
0.62%
52 weeks high
3.50
52 weeks low
0.73

In brief

XPhyto is a science-based cannabis company focused on formulation, clinical validation, and emerging European markets. XPhyto’s 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH, has been granted a unique German cannabis cultivation and extraction licence for scientific purposes by the German Federal Institute for Drugs and Medical Devices (BfArM). XPhyto is pursuing additional opportunities in Germany including cultivation, processing, manufacturing, import, and distribution. 

Deep dive We explore the investor case for growth companies

Snapshot

It has been a busy start to 2020 for XPhyto and it was quick to move amid the global coronavirus crisis